ONPPF
Price:
$0.265
Market Cap:
$1.16B
Oncopeptides AB (publ), a biotech company, develops pharmaceuticals drugs for the treatment of cancer in the United States, Europe, and internationally. Its lead product candidate is melflufen, an anti-cancer peptide drug conjugate for the treatment of relapsed refractory multiple myeloma in adult patients. Oncopeptides AB (publ) was incorporated in 2000 and is headquartered in Stockholm, Sweden.
Industry
Biotechnology
IPO Date
2020-12-16
Stock Exchange
OTC
Ticker
ONPPF
According to Oncopeptides AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 1.14B. This represents a change of 109.47% compared to the average of 543.89M of the last 4 quarters.
The mean historical Enterprise Value of Oncopeptides AB (publ) over the last ten years is 1.96B. The current 1.14B Enterprise Value has changed 5.71% with respect to the historical average. Over the past ten years (40 quarters), ONPPF's Enterprise Value was at its highest in in the December 2020 quarter at 7.30B. The Enterprise Value was at its lowest in in the June 2016 quarter at 0.
Average
1.96B
Median
1.17B
Minimum
103.01M
Maximum
6.72B
Discovering the peaks and valleys of Oncopeptides AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 266.89%
Maximum Annual Enterprise Value = 6.72B
Minimum Annual Increase = -98.47%
Minimum Annual Enterprise Value = 103.01M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 222.82M | -65.47% |
| 2023 | 645.27M | 70.74% |
| 2022 | 377.92M | 266.89% |
| 2021 | 103.01M | -98.47% |
| 2020 | 6.72B | 78.98% |
| 2019 | 3.76B | 2.54% |
| 2018 | 3.66B | 104.27% |
| 2017 | 1.79B | 55.99% |
| 2016 | 1.15B | -3.20% |
| 2015 | 1.19B | 0.82% |
The current Enterprise Value of Oncopeptides AB (publ) (ONPPF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
415.34M
5-year avg
1.61B
10-year avg
1.96B
Oncopeptides AB (publ)’s Enterprise Value is greater than Herantis Pharma Oyj (50.66M), greater than Abliva AB (publ) (683.00M), greater than Biostage, Inc. (57.29M), greater than Mindset Pharma Inc. (66.42M), greater than Relief Therapeutics Holding AG (24.49M), greater than Medivir AB (publ) (411.40M), less than MCI Onehealth Technologies Inc. (0), greater than Karolinska Development AB (publ) (52.14M), greater than Alpha Cognition Inc. (34.21M), greater than Small Pharma Inc. (34.34M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 50.66M | $59.47M | |
| 683.00M | $45.13M | |
| 57.29M | $57.82M | |
| 66.42M | $54.51M | |
| 24.49M | $44.94M | |
| 411.40M | $45.78M | |
| 0 | $54.04M | |
| 52.14M | $68.85M | |
| 34.21M | $35.66M | |
| 34.34M | $37.51M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oncopeptides AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Oncopeptides AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Oncopeptides AB (publ)'s Enterprise Value?
What is the highest Enterprise Value for Oncopeptides AB (publ) (ONPPF)?
What is the 3-year average Enterprise Value for Oncopeptides AB (publ) (ONPPF)?
What is the 5-year average Enterprise Value for Oncopeptides AB (publ) (ONPPF)?
How does the current Enterprise Value for Oncopeptides AB (publ) (ONPPF) compare to its historical average?